Vicky Holliday, 38, is reluctant to have a second child with her partner Keith Newell after their first - one-year-old Jessica Newell - was born with a devastating disease caused by faulty mitochondrial DNA.
Holliday is being treated by a British scientist who has spent 15 years developing a technique to use DNA from a second mother alongside her own nucleus and her partner's sperm.
Holliday's appeal to MPs came ahead of a vote on Tuesday on whether to amend the Human Fertilisation and Embryology Act to make the method legal.
In her appeal, Holliday begged MPs to make Britain the first country to introduce legislation allowing the procedure.
"It's a very exciting moment," said Holliday, a management consultant in Buckinghamshire.
"It would mean so much to us to be able to have a healthy child."
"When you're given the worst possible news it helps to have a little bit of hope," she said.
Mitochondria are self- contained units within the cell that produce its energy and have many other vital functions, which include producing hormones and other essential compounds. Supporters say the amount of DNA they contain is so small that any alterations will have only a small impact on the child.
However, critics counter that this is unproven. The change is being opposed by the Church of England.
Although flawed mitochondrial DNA is passed down the mother's side, her mother and grandmother were unaffected and there was no reason for anxiety.
However, it turned out that Jessica was among the roughly one in 5,000 British children who inherit mitochondrial disorders and at six months her development slowed. Then she started to regress.
It is not certain that this technique would be used for Holliday, who is being treated by Doug Turnbull, professor of neurology at Newcastle University. Another method involves implanting the nucleus from her egg into a donated egg before fertilisation, avoiding the need to throw away fused DNA.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
